P-1322. Transmission Dynamics of <i>Escherichia coli</i> Sequence Type 131 Amongst Community Dwelling Households: A Prospective Cohort Study

Abstract Background Escherichia coli sequence type 131 (E. coli ST131) is a global pandemic clone associated with the rapid dissemination of CTX-M–class extended spectrum β-lactamase (ESBL) genes, conferring resistance to several antibiotic classes, and is a major cause of both healthcare and community-acquired extraintestinal pathogenic E. coli (ExPEC) infections. The drivers of E. coli ST131 pandemicity are not well-understood. Figure 1. Prospective cohort study enrollment flowchart Methods Between February 2017 to November 2018, 34 hospitalized patients with E. coli positive cultures (including half with ST131-positive cultures) and their household coresidents were recruited to a prospective cohort study in which all household members provided up to 12 stool samples at 2-6 week intervals. The samples were screened for E. coli ST131 isolates using quantitative polymerase chain reaction (qPCR), and short-read whole genome sequencing (WGS) was conducted on all E. coli ST131-positive isolates. Figure 2. Model estimates of E. coli ST131 acquisition rate and carriage duration Results Nine individuals (7.25%) carried E. coli ST131 for a median of 86.35 days [80% CrI: 30.03-188.8] (over three times higher than the cohort average of 27.33 days [80% CrI: 20.00-36.74]) and at high densities. The household coresidents of these individuals acquired E. coli ST131 at approximately twice the rate of those who did not coreside with a persistent high-density carrier (0.031 per day [80% CrI: .012-.10] and 0.016 per day [0.006-0.05], respectively; Odds Ratio: 2.61 [95% CI: 1.36 to 5.00] (p &amp;lt; 0.01)). WGS analysis identified a high degree of sequence similarity between E. coli ST131 isolates obtained from different individuals and at multiple non-sequential timepoints in four of the nine families in which a high-density persistent carrier was resident, indicating potential repeated transmission events. Multivariate and univariate regression analysis of risk factors associated with E. coli ST131 acquisition Conclusion These findings indicate that a proportion of high-density asymptomatic carriers in the community may act as reservoirs for E. coli ST131, with frequent transmission to household contacts representing a key driver of E. coli ST131’s pandemic success. Further studies in other settings are needed to understand high-density persistent carrier status and address this potential community-level reservoir in order to contain this multi-resistant pathogen and reduce its clinical impact. Disclosures Paul Tambyah, MBBS (S'pore), Diplomate, American Board of Internal Medicine and Infectious Diseases, Moderna: Grant/Research Support|Sanofi-Pasteur: Grant/Research Support

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2025-01-29
DOI
https://doi.org/10.1093/ofid/ofae631.1501
Primary Topic
Escherichia coli research studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-1322. Transmission Dynamics of Escherichia coli Sequence Type 131 Amongst Community Dwelling Households: A Prospective Cohort Study

En Ying Tan, Wei Cong Tan, Yin Mo, Kyaw Thu Aung et al.
Open Forum Infectious Diseases
Escherichia coli research studies
article

P-1322. Transmission Dynamics of Escherichia coli Sequence Type 131 Amongst Community Dwelling Households: A Prospective Cohort Study

En Ying Tan, Wei Cong Tan, Yin Mo, Kyaw Thu Aung, Paul Anantharajah Tambyah, Cheng Yee Tang, Jeanette Teo, Ivan Seah, Rick Ong Twee Hee, Ritu Banerjee, Shweta Singh, R. Pérez, Wesley Yeung Lok Kin, Kithalaksmi Vignesvaran
article en

Abstract

Abstract Background Escherichia coli sequence type 131 (E. coli ST131) is a global pandemic clone associated with the rapid dissemination of CTX-M–class extended spectrum β-lactamase (ESBL) genes, conferring resistance to several antibiotic classes, and is a major cause of both healthcare and community-acquired extraintestinal pathogenic E. coli (ExPEC) infections. The drivers of E. coli ST131 pandemicity are not well-understood. Figure 1. Prospective cohort study enrollment flowchart Methods Between February 2017 to November 2018, 34 hospitalized patients with E. coli positive cultures (including half with ST131-positive cultures) and their household coresidents were recruited to a prospective cohort study in which all household members provided up to 12 stool samples at 2-6 week intervals. The samples were screened for E. coli ST131 isolates using quantitative polymerase chain reaction (qPCR), and short-read whole genome sequencing (WGS) was conducted on all E. coli ST131-positive isolates. Figure 2. Model estimates of E. coli ST131 acquisition rate and carriage duration Results Nine individuals (7.25%) carried E. coli ST131 for a median of 86.35 days [80% CrI: 30.03-188.8] (over three times higher than the cohort average of 27.33 days [80% CrI: 20.00-36.74]) and at high densities. The household coresidents of these individuals acquired E. coli ST131 at approximately twice the rate of those who did not coreside with a persistent high-density carrier (0.031 per day [80% CrI: .012-.10] and 0.016 per day [0.006-0.05], respectively; Odds Ratio: 2.61 [95% CI: 1.36 to 5.00] (p &amp;lt; 0.01)). WGS analysis identified a high degree of sequence similarity between E. coli ST131 isolates obtained from different individuals and at multiple non-sequential timepoints in four of the nine families in which a high-density persistent carrier was resident, indicating potential repeated transmission events. Multivariate and univariate regression analysis of risk factors associated with E. coli ST131 acquisition Conclusion These findings indicate that a proportion of high-density asymptomatic carriers in the community may act as reservoirs for E. coli ST131, with frequent transmission to household contacts representing a key driver of E. coli ST131’s pandemic success. Further studies in other settings are needed to understand high-density persistent carrier status and address this potential community-level reservoir in order to contain this multi-resistant pathogen and reduce its clinical impact. Disclosures Paul Tambyah, MBBS (S'pore), Diplomate, American Board of Internal Medicine and Infectious Diseases, Moderna: Grant/Research Support|Sanofi-Pasteur: Grant/Research Support

Open Forum Infectious DiseasesVol. 12(Supplement_1)
National University of Singapore (SG), National University Heart Centre Singapore (SG), National University Hospital (SG), National University Health System (SG), Vanderbilt University Medical Center (US)
Openalex Percentile: Top 99%
Escherichia coli research studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.